The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancerOA
The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer
Yilin Chen;Ye Qin;Man Yang;Wei Li;Minyi Cheng;Yuhong Huang;Teng Zhu;Kun Wang
Department of Breast Cancer,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,ChinaDepartment of Breast Cancer,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,ChinaThe Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,ChinaDepartment of Breast Cancer,The First People's Hospital of Foshan,Foshan 528000,ChinaDepartment of Breast Cancer,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,ChinaDepartment of Breast Cancer,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,ChinaDepartment of Breast Cancer,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,ChinaDepartment of Breast Cancer,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,China||The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China
Breast cancerradiomicsneoadjuvant chemotherapydeep learningpathologic complete response
Breast cancerradiomicsneoadjuvant chemotherapydeep learningpathologic complete response
《癌症生物学与医学（英文版）》 2026 (3)
343-362,20
This study is supported by grants from National Science and Technology Major Project(Grant No.2025ZD0544000),National Natural Science Foundation of China(Grant No.82171898),Deng Feng Project of High-level Hospital Construction(Grant No.DFJHBF202109),Beijing Science and Technology Innovation Medical Development Foundation(Grant No.KC2023-JX-0270-09),and Development Center for Medical Science&Technology National Health commission of the People's Republic of China(Grant No.WKZX2025RL0130).Funding sources were not involved in the study design,data collection,analysis and interpretation,writing of the report,or decision to submit the article for publication.
评论